Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Biosimilars of Rituximab Industry Analysis 2021: Industry Growth Factors, Types, Applications, Top Players, Regional Insights To 2027

  • Purchase Options

 

Summary

The global Biosimilars of Rituximab Industry is expected to witness a CAGR of xx% over the forecast period 2021-2027 and is expected to reach US$ xx million in 2027, from US$ xx million in 2020. 

The Biosimilars of Rituximab Industry report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST, and Porter’s Five Forces analyses of the Biosimilars of Rituximab Industry, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Amgen
  • AryoGen Pharmed
  • Biocad
  • Cadila Pharmaceuticals
  • Celltrion
  • Dr Reddy's Laboratories
  • Teva
  • Hetero Group
  • Innovent Biologics
  • Intas Biopharmaceuticals
  • Mylan
  • Probiomed
  • TRPharma
  • Zenotech Laboratories

By Product Type, the market is primarily segmented into:

  • 500mg
  • 100mg
  • Other

By Applications, the market is segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy

The report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

The objective of the Biosimilars of Rituximab Industry Report:

  • To assess the size of the market by value and volume
  • Analyze the Biosimilars of Rituximab Industry in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Biosimilars of Rituximab Industry in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of-the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact the growth of the Biosimilars of Rituximab Industry

The Biosimilars of Rituximab Industry engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Biosimilars of Rituximab Industry from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type, and application, 2020 are considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Report Overview


1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars of Rituximab Industry Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Biosimilars of Rituximab Industry Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Biosimilars of Rituximab Industry
1.6.1 How the Covid-19 is Affecting the Biosimilars of Rituximab Industry
1.6.1.1 Biosimilars of Rituximab Industry Business Impact Assessment - Covid-19
1.6.2 Market Trends and Biosimilars of Rituximab Industry Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered


2 Global Growth Trends by Regions


2.1 Biosimilars of Rituximab Industry Perspective (2015-2027)
2.2 Biosimilars of Rituximab Industry Growth Trends by Regions
2.2.1 Biosimilars of Rituximab Industry Size by Regions: 2015 VS 2021 VS 2027
2.2.2 Biosimilars of Rituximab Industry Historic Market Share by Regions (2015-2021)
2.2.3 Biosimilars of Rituximab Industry Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Biosimilars of Rituximab Industry Growth Strategy
2.3.6 Primary Interviews with Key Biosimilars of Rituximab Industry Players (Opinion Leaders)


3 Competition Landscape by Key Players


3.1 Global Top Biosimilars of Rituximab Industry Players by Market Size
3.1.1 Global Top Biosimilars of Rituximab Industry Players by Revenue (2015-2021)
3.1.2 Global Biosimilars of Rituximab Industry Revenue Market Share by Players (2015-2021)
3.1.3 Global Biosimilars of Rituximab Industry Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biosimilars of Rituximab Industry Concentration Ratio
3.2.1 Global Biosimilars of Rituximab Industry Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biosimilars of Rituximab Industry Revenue in 2019
3.3 Biosimilars of Rituximab Industry Key Players Head office and Area Served
3.4 Key Players Biosimilars of Rituximab Industry Product Solution and Service
3.5 Date of entering into Biosimilars of Rituximab Industry
3.6 Mergers & Acquisitions, Expansion Plans


4 Breakdown Data by Type (2015-2027)


4.1 Global Biosimilars of Rituximab Industry Historic Market Size by Type (2015-2021)
4.2 Global Biosimilars of Rituximab Industry Forecasted Market Size by Type (2021-2027)


5 Biosimilars of Rituximab Industry Breakdown Data by Application (2015-2027)


5.1 Global Biosimilars of Rituximab Industry Size by Application (2015-2021)
5.2 Global Biosimilars of Rituximab Industry Forecasted Market Size by Application (2021-2027)


6 North America


6.1 North America Biosimilars of Rituximab Industry Size (2015-2021)
6.2 Biosimilars of Rituximab Industry Key Players in North America (2019-2021)
6.3 North America Biosimilars of Rituximab Industry Size by Type (2015-2021)
6.4 North America Biosimilars of Rituximab Industry Size by Application (2015-2021)


7 Europe


7.1 Europe Biosimilars of Rituximab Industry Size (2015-2021)
7.2 Biosimilars of Rituximab Industry Key Players in Europe (2019-2021)
7.3 Europe Biosimilars of Rituximab Industry Size by Type (2015-2021)
7.4 Europe Biosimilars of Rituximab Industry Size by Application (2015-2021)


8 China


8.1 China Biosimilars of Rituximab Industry Size (2015-2021)
8.2 Biosimilars of Rituximab Industry Key Players in China (2019-2021)
8.3 China Biosimilars of Rituximab Industry Size by Type (2015-2021)
8.4 China Biosimilars of Rituximab Industry Size by Application (2015-2021)


9 Japan


9.1 Japan Biosimilars of Rituximab Industry Size (2015-2021)
9.2 Biosimilars of Rituximab Industry Key Players in Japan (2019-2021)
9.3 Japan Biosimilars of Rituximab Industry Size by Type (2015-2021)
9.4 Japan Biosimilars of Rituximab Industry Size by Application (2015-2021)


10 Southeast Asia


10.1 Southeast Asia Biosimilars of Rituximab Industry Size (2015-2021)
10.2 Biosimilars of Rituximab Industry Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Biosimilars of Rituximab Industry Size by Type (2015-2021)
10.4 Southeast Asia Biosimilars of Rituximab Industry Size by Application (2015-2021)


11 India


11.1 India Biosimilars of Rituximab Industry Size (2015-2021)
11.2 Biosimilars of Rituximab Industry Key Players in India (2019-2021)
11.3 India Biosimilars of Rituximab Industry Size by Type (2015-2021)
11.4 India Biosimilars of Rituximab Industry Size by Application (2015-2021)


12 Central & South America


12.1 Central & South America Biosimilars of Rituximab Industry Size (2015-2021)
12.2 Biosimilars of Rituximab Industry Key Players in Central & South America (2019-2021)
12.3 Central & South America Biosimilars of Rituximab Industry Size by Type (2015-2021)
12.4 Central & South America Biosimilars of Rituximab Industry Size by Application (2015-2021)


13 Key Players Profiles


13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Biosimilars of Rituximab Industry Introduction
13.4 Biosimilars of Rituximab Industry Business (2015-2021)
13.5 Recent Development


14 Analyst's Viewpoints/Conclusions


15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details


List of Table


Table 1. Biosimilars of Rituximab Industry Key Market Segments
Table 2. Key Players Covered: Ranking by Biosimilars of Rituximab Industry Revenue
Table 3. Ranking of Global Top Biosimilars of Rituximab Industry Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biosimilars of Rituximab Industry Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Biosimilars of Rituximab Industry Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Biosimilars of Rituximab Industry Players to Combat Covid-19 Impact
Table 10. Global Biosimilars of Rituximab Industry Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Biosimilars of Rituximab Industry Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global Biosimilars of Rituximab Industry Size by Regions (2015-2021) (US$ Million)
Table 13. Global Biosimilars of Rituximab Industry Share by Regions (2015-2021)
Table 14. Global Biosimilars of Rituximab Industry Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global Biosimilars of Rituximab Industry Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Biosimilars of Rituximab Industry Growth Strategy
Table 20. Main Points Interviewed from Key Biosimilars of Rituximab Industry Players
Table 21. Global Biosimilars of Rituximab Industry Revenue by Players (2015-2021) (Million US$)
Table 22. Global Biosimilars of Rituximab Industry Share by Players (2015-2021)
Table 23. Global Top Biosimilars of Rituximab Industry Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars of Rituximab Industry as of 2019)
Table 24. Global Biosimilars of Rituximab Industry by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biosimilars of Rituximab Industry Product Solution and Service
Table 27. Date of entering into Biosimilars of Rituximab Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 30. Global Biosimilars of Rituximab Industry Size Share by Type (2015-2021)
Table 31. Global Biosimilars of Rituximab Industry Revenue Market Share by Type (2021-2027)
Table 31. Global Biosimilars of Rituximab Industry Size Share by Application (2015-2021)
Table 33. Global Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 34. Global Biosimilars of Rituximab Industry Size Share by Application (2021-2027)
Table 35. North America Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 37. North America Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 38. North America Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 39. North America Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 40. North America Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 41. Europe Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 43. Europe Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 44. Europe Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 45. Europe Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 46. Europe Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 47. China Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 48. China Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 49. China Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 50. China Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 51. China Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 52. China Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 53. Japan Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 55. Japan Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 56. Japan Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 57. Japan Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 58. Japan Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 61. Southeast Asia Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 63. Southeast Asia Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 65. India Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 66. India Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 67. India Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 68. India Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 69. India Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 70. India Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 71. Central & South America Key Players Biosimilars of Rituximab Industry Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Biosimilars of Rituximab Industry Share (2019-2021)
Table 73. Central & South America Biosimilars of Rituximab Industry Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Biosimilars of Rituximab Industry Share by Type (2015-2021)
Table 75. Central & South America Biosimilars of Rituximab Industry Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Biosimilars of Rituximab Industry Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Biosimilars of Rituximab Industry Business (2015-2021) (Million US$)
Table 81. Recent Development


List of Figures


Figure 1. Global Biosimilars of Rituximab Industry Share by Type: 2021 VS 2027
Figure 2. Global Biosimilars of Rituximab Industry Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Biosimilars of Rituximab Industry Report Years Considered
Figure 8. Global Biosimilars of Rituximab Industry Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global Biosimilars of Rituximab Industry Share by Regions: 2021 VS 2027
Figure 10. Global Biosimilars of Rituximab Industry Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Biosimilars of Rituximab Industry Share by Players in 2019
Figure 13. Global Top Biosimilars of Rituximab Industry Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Biosimilars of Rituximab Industry as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Biosimilars of Rituximab Industry Revenue in 2019
Figure 15. North America Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Biosimilars of Rituximab Industry Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us